VANCOUVER, CANADA / ACCESSWIRE / June 16, 2020 / First Mining Gold Corp. ("First Mining" or the "Company") (TSX:FF)(OTCQX:FFMGF)(FRA:FMG) is pleased to announce the voting results from the Company's annual general meeting of shareholders held virtually in Vancouver on June 16, 2020 (the "2020 AGM").

A total of 235,125,295 common shares of First Mining were represented at the 2020 AGM, representing 37.73% of the Company's outstanding common shares as at the record date of April 30, 2020. Shareholders voted in favour of all matters brought before the meeting. All five director nominees listed in the Company's management information circular dated May 6, 2020 (the "Circular") were elected as follows:

Election of Directors

Director Nominee

Votes For

% For

Votes Withheld

% Withheld

Keith Neumeyer

97,936,953

98.34%

1,650,518

1.66%

Richard Lock

97,591,863

98.00%

1,995,608

2.00%

Aoife McGrath

97,566,069

97.97%

2,021,402

2.03%

Raymond Polman

97,554,919

97.96%

2,032,552

2.04%

Daniel W. Wilton

97,572,035

97.98%

2,015,436

2.02%

Detailed voting results for the meeting are available on SEDAR at www.sedar.com.

Appointment of Auditor

Outcome of the Vote

Votes For

% For

Votes Withheld

% Withheld

Carried

226,734,380

96.43%

8,390,915

3.57%

About First Mining Gold Corp.

First Mining is a Canadian gold developer focused on the development and permitting of the Springpole Gold Project in northwestern Ontario. Springpole is one of the largest undeveloped gold projects in Canada, currently hosting a mineral resource base of 4.67 million ounces of gold in the Indicated category and 0.23 million ounces of gold in the Inferred category1. A Pre-Feasibility Study is underway, with completion targeted in early 2021, and permitting is on-going with submission of the Environmental Impact Statement targeted for 2021. The Company is also in the process of closing its announced transaction with Treasury Metals Inc., after which it will hold a large equity position in Treasury that is advancing the Goliath-Goldlund gold project towards construction. First Mining's eastern Canadian property portfolio also includes the Pickle Crow (being advanced in partnership with Auteco Minerals Ltd.), Cameron, Hope Brook, Duparquet, Duquesne, and Pitt gold projects.

First Mining was created in 2015 by Mr. Keith Neumeyer, founding President and CEO of First Majestic Silver Corp.

ON BEHALF OF FIRST MINING GOLD CORP.

Daniel W. Wilton

Chief Executive Officer and Director

For further information, please contact:

Spiros Cacos | Vice President, Investor Relations
Direct: +1.604.639.8827 | Toll Free: 1.844.306.8827 | Email: info@firstmininggold.com
www.firstmininggold.com

Note:

1. These numbers are from the independent technical report titled "Preliminary Economic Assessment Update for the Springpole Gold Project, Ontario, Canada", dated November 5, 2019, which was prepared by SRK Consulting (Canada) Inc. in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects ("NI 43-101") and is available at www.sedar.com under First Mining's SEDAR profile. Readers are cautioned that the PEA is preliminary in nature, it includes inferred mineral resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves, and there is no certainty that the PEA will be realized.

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain "forward-looking information" and "forward-looking statements" (collectively "forward-looking statements") within the meaning of applicable Canadian and United States securities legislation including the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date of this news release. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "plans", "projects", "intends", "estimates", "envisages", "potential", "possible", "strategy", "goals", "objectives", or variations thereof or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions.

Forward-looking statements in this news release relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events and include, but are not limited to, statements with respect to: (i) the Company's focus on developing and permitting Springpole;(ii) timing for the completion of a Pre-Feasibility for Springpole; (iii) timing for the submission of an Environmental Impact Statement for Springpole; (iv) closing of the transaction with Treasury Metals Inc. and the Company holding a large equity position in Treasury Metals Inc. after closing; and (v) realizing the value of the Company's gold projects for the Company's shareholders. All forward-looking statements are based on First Mining's or its consultants' current beliefs as well as various assumptions made by them and information currently available to them. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the respective parties, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: fluctuations in the spot and forward price of gold, silver, base metals or certain other commodities; fluctuations in the currency markets (such as the Canadian dollar versus the U.S. dollar); changes in national and local government, legislation, taxation, controls, regulations and political or economic developments; risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected formations, pressures, cave-ins and flooding); the presence of laws and regulations that may impose restrictions on mining; employee relations; relationships with and claims by local communities, indigenous populations and other stakeholders; availability and increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development; title to properties.; and the additional risks described in the Company's Annual Information Form for the year ended December 31, 2019 filed with the Canadian securities regulatory authorities under the Company's SEDAR profile at www.sedar.com, and in the Company's Annual Report on Form 40-F filed with the SEC on EDGAR.

First Mining cautions that the foregoing list of factors that may affect future results is not exhaustive. When relying on our forward-looking statements to make decisions with respect to First Mining, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. First Mining does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by the Company or on our behalf, except as required by law.

Cautionary Note to United States Investors

This news release has been prepared in accordance with the requirements of the securities laws in effect in Canada, which differ from the requirements of U.S. securities laws. Unless otherwise indicated, all resource and reserve estimates included in this news release have been prepared in accordance with NI 43-101 and the Canadian Institute of Mining, Metallurgy, and Petroleum 2014 Definition Standards on Mineral Resources and Mineral Reserves. NI 43-101 is a rule developed by the Canadian Securities Administrators which establishes standards for all public disclosure an issuer makes of scientific and technical information concerning mineral projects. Canadian standards, including NI 43-101, differ significantly from the requirements of the SEC, and mineral resource and reserve information contained herein may not be comparable to similar information disclosed by U.S. companies. In particular, and without limiting the generality of the foregoing, the term "resource" does not equate to the term "reserves". Under U.S. standards, mineralization may not be classified as a "reserve" unless the determination has been made that the mineralization could be economically and legally produced or extracted at the time the reserve determination is made. The SEC's disclosure standards normally do not permit the inclusion of information concerning "measured mineral resources", "indicated mineral resources" or "inferred mineral resources" or other descriptions of the amount of mineralization in mineral deposits that do not constitute "reserves" by U.S. standards in documents filed with the SEC. Investors are cautioned not to assume that any part or all of mineral deposits in these categories will ever be converted into reserves. U.S. investors should also understand that "inferred mineral resources" have a great amount of uncertainty as to their existence and great uncertainty as to their economic and legal feasibility. It cannot be assumed that all or any part of an "inferred mineral resource" will ever be upgraded to a higher category. Under Canadian rules, estimated "inferred mineral resources" may not form the basis of feasibility or pre-feasibility studies except in rare cases. Investors are cautioned not to assume that all or any part of an "inferred mineral resource" exists or is economically or legally mineable. Disclosure of "contained ounces" in a resource is permitted disclosure under Canadian regulations; however, the SEC normally only permits issuers to report mineralization that does not constitute "reserves" by SEC standards as in-place tonnage and grade without reference to unit measures. The requirements of NI 43-101 for identification of "reserves" are also not the same as those of the SEC, and reserves reported by the Company in compliance with NI 43-101 may not qualify as "reserves" under SEC standards. Accordingly, information concerning mineral deposits set forth herein may not be comparable with information made public by companies that report in accordance with U.S. standards.

SOURCE: First Mining Gold Corp.

ReleaseID: 594153

VANCOUVER, BC / ACCESSWIRE / June 16, 2020 / GREAT ATLANTIC RESOURCES CORP. (TSXV:GR)(FRA:PH01) (the "Company" or "Great Atlantic") is pleased to announce it has made 2020 option payments to vendors for three New Brunswick properties. These are the Kagoot Brook Cobalt Property, Glenelg Vanadium Property and Mascarene (polymetallic) Property. Great Atlantic can acquire 100% in all three properties. Other New Brunswick properties including Keymet, Porcupine, Mount Raymond and McDougall Road are 100% owned by Great Atlantic.

Kagoot Brook Cobalt Property

Great Atlantic optioned the Kagoot Brook Cobalt Property during 2018 (Company News Release of January 10, 2018), located in north-central New Brunswick. Great Atlantic has made the 2020 (second anniversary) cash payment to the vendor for the property. Great Atlantic can acquire 100% interest in the property. Since entering into the option agreement, Great Atlantic has expanded the Kagoot Brook Cobalt Property to the current approximate 4,233 hectare area. The property covers reported cobalt stream silt geochemical anomalies, some reported to be highly anomalous (reported up to 6,000 ppm cobalt or 0.6% cobalt). The property is located approximately 85 kilometers southwest of Bathurst along the southwest margin of the famous Bathurst Mining Camp. Great Atlantic has optioned the Kagoot Brook Cobalt Property to Explorex Resources Inc whereby Explorex Resources Inc. can acquire a 75% interest in the property (Company News Release of February 14, 2018).

Follow-up stream silt sampling programs was conducted by Explorex Resources Inc. during 2018 on the Kagoot Brook Property. It was reported the silt sample results from the 2018 program also revealed a significant concentration of and a strong relationship of cobalt with manganese and associated base metals (nickel, copper, lead and zinc) (Explorex Resources Inc. News Release of November 5, 2018).

Glenelg Vanadium Property

Great Atlantic optioned the Glenelg Vanadium Property during 2019 (Company News Release of May 6, 2019), located in southwest New Brunswick. Great Atlantic has made the 2020 (first anniversary) cash payment to the vendors for the property. Great Atlantic can acquire 100% interest in the property. Since entering into the option agreement, Great Atlantic has expanded the Glenelg Vanadium Property to the current approximate 3,500-hectare area.

The Glenelg Vanadium Property hosts vanadium and titanium mineralization, occurring within the Bocabec Gabbro Complex. A 2018 outcrop grab sample collected by the Company from a magnetic layer in the Bocabec Gabbro Complex returned 0.188% vanadium (0.33% V2O5), 10.3% TiO2 and 25.71% iron (Company News Release of May 6, 2019). This sample was collected by a qualified person and analyzed by ALS Canada Ltd. by XRF Fusion. The area of this outcrop has not been tested by drilling. The 2019 drilling program did not test this target area due to wet late-fall conditions. Another 2018 bedrock grab sample from the same area was reported to return 0.234% vanadium (0.42% V2O5), 7.34% titanium (12.2%TiO2) and 28.8% iron. This sample was collected by one of the Company's option partners for the property. This sample has not been verified by a Qualified Person.

Layered Bocabec Gabbro Complex

Polymetallic veins are reported within the Glenelg Vanadium Property. A grab sample collected during 2006 was reported to return 2.6 grams per tonne (g/t) gold and 0.65% cobalt. A 2013 grab sample from a sulfide vein was reported to return 14 g/t gold, 1.28% bismuth and 0.12% cobalt. These samples have not been verified by a Qualified Person.

Mascarene Property

Great Atlantic optioned the Mascarene Property during early 2018 (Company News Release of February 13, 2018), located in southwest New Brunswick. Great Atlantic has made the 2020 (second anniversary) cash payment to the vendors for the property. Great Atlantic can acquire 100% interest in the property. Since entering into the option agreement, Great Atlantic has expanded the Mascarene Property to the current approximate 2,080-hectare area.

The Mascarene Property is reported to contain multiple mineral occurrences with cobalt, copper, nickel, zinc, lead, gold and / or silver, some with historic workings dating back to the 1800s. The Company verified zinc-lead-silver and gold-copper-nickel-cobalt mineralization in rubble near historic workings at two reported mineral occurrences during 2018 (Company News Release of October 17, 2018). Rock grab samples collected by the Company during 2018 from rubble at the reported Simpson Prospects occurrence returned 12.35% zinc, 4.34% lead and 41 g/t silver; and 12.6% zinc. Rock grab samples collected by the Company during 2018 from rubble at the Oliver-Cameron Mine Occurrence returned 1.84 – 5.02% copper and up to 2.01 g/t gold, 0.22% nickel and 0.14% cobalt. A Qualified Person supervised the 2018 program and verified the sample data. The Company has not verified other reported mineral occurrences within the property.

David Martin, P.Geo., a Qualified Person as defined by NI 43-101 and VP Exploration for Great Atlantic, is responsible for the technical information contained in this News Release.

The Company is also pleased to announce it has closed the final tranche of its non-brokered private placement previously announced on May 25, 2020. The final tranche consisted of 238,095 flow through shares at a price of $0.42 per share for gross proceeds of $100,000. Each Flow-Through share consists of one common share that qualifies as a "flow-through share" as defined in subsection 66(15) of the Income Tax Act. The net proceeds from the offering will be used for exploration expenses on the Company's mineral properties in Atlantic Canada. All securities issued in connection with the Offering will be subject to a hold period expiring October 10, 2020.

Christopher Anderson a director and/or officer of the Company, participated in the Offering constituting a related party transaction pursuant to TSX Venture Exchange Policy 5.9 and Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company relied on section 5.5(a) of MI 61-101 for an exemption from the formal valuation requirement and section 5.7(1)(a) of MI 61-101 for an exemption from the minority shareholder approval requirement of MI 61-101 as the fair market value of the transaction did not exceed 25% of the Company's market capitalization.

On Behalf of the Board of Directors

"Christopher R Anderson"

Mr. Christopher R. Anderson "Always be positive, strive for solutions, and never give up"
President CEO Director
604-488-3900 – Dir

Investor Relations:
Please call 604-488-3900

About Great Atlantic Resources Corp.: Great Atlantic Resources Corp. is a Canadian exploration company focused on the discovery and development of mineral assets in the resource-rich and sovereign risk-free realm of Atlantic Canada, one of the number one mining regions of the world. Great Atlantic is currently surging forward building the company utilizing a Project Generation model, with a special focus on the most critical elements on the planet that are prominent in Atlantic Canada, Antimony, Tungsten and Gold.

This press release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address future exploration drilling, exploration activities and events or developments that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include exploitation and exploration successes, continued availability of financing, and general economic, market or business conditions.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Great Atlantic Resources Corp.

ReleaseID: 593973

Alliance Fulfills Advisor Demand for Turnkey Outsourced Compliance and Investment Solutions

CHICAGO, IL / ACCESSWIRE / June 16, 2020 / GeoWealth, a leading financial technology and turnkey asset management platform (TAMP), today announced a strategic alliance with Foreside Financial Group ("Foreside"), a global provider of compliance technology solutions and product distribution services to the asset and wealth management industries. Through this partnership, financial advisors that are either breaking away and becoming independent, or are founding a registered investment advisory firm ("RIA"), will have access to the full, turnkey investment, technology, and compliance infrastructure they need to successfully launch their businesses.

"Before an advisor launches an RIA, they must select both a compliance and technology partner. With the added complexities for advisors now working remotely during COVID, we are focused on simplifying and streamlining what is often characterized as an overwhelming process," said, Colin Falls, President of GeoWealth. "We are excited to announce our partnership with Foreside. Their industry-leading compliance offerings combined with our turnkey, modern platform will help entrepreneurial advisors successfully make the transition to independence."

GeoWealth's next-generation turnkey asset management platform is powered by its proprietary enterprise technology that comprehensively supports advisors. This cloud-based platform simplifies the wealth management process by allowing advisors to seamlessly manage all aspects of their business. GeoWealth's flexible, outsourced model management program includes both advisor-managed and third-party models. Their third-party model marketplace features investment solutions from some of the industry's most trusted asset managers, including J.P. Morgan, PIMCO, Fidelity, State Street Global Advisors, Van Eck, and Global X.

Foreside's Compliance Programs for RIAs are designed by experienced compliance experts and tailored to fulfill the ongoing compliance obligations of RIAs. Each level of support provides a dedicated consultant, supported by a team of compliance professionals, to deliver proactive services and continuous support to your firm. Together, GeoWealth and Foreside's synergistic offerings will unite, allowing advisors to access their shared resources, knowledge, and platforms.

"Foreside continues to bring to our clients best-in-class proprietary technology and partnerships with providers like GeoWealth who are pioneers in the industry. In doing so, we help our clients gain access to products that help them innovate, improve, and grow" said, Mark Alcaide, Senior Managing Director, Foreside. GeoWealth's end-to-end advisor platform allows a holistic solution that assists our clients with their technology, investment, and back-office needs."

About GeoWealth

GeoWealth's cloud-based financial technology platform empowers advisors to grow faster and to serve their clients more efficiently. With over 500 advisors and more than 60,000 accounts on its platform today, GeoWealth provides advisors flexible portfolio management, performance reporting, billing and risk profiling. GeoWealth also offers a diversified lineup of turnkey model portfolios. More information is available at http://www.geowealth.com.

About Foreside

Foreside delivers comprehensive advice and best-in-class technology solutions to clients in the global asset and wealth management industries. Foreside distributes more than $1 trillion of product through their 20 limited purpose broker-dealers. For 15 years, Foreside's suite of services and platform-based model have helped automate and simplify compliance and marketing for clients. Foreside works with pooled investment products, investment advisors, broker-dealers, global asset managers and other financial institutions.

By harnessing state-of-the-art technology, Foreside helps firms address and shape today's regulatory environment, drive operational efficiency and growth, and focus on value-adding work. Foreside is headquartered in Portland, Maine, with numerous regional offices, including New York and Boston. For more information on Foreside's suite of services, please visit www.foreside.com.

Media Contact:

Jacqueline Silva
Caliber Corporate Advisers
jacqueline@calibercorporate.com
917-880-2464

SOURCE: GeoWealth

ReleaseID: 593948

TEMPE, AZ / ACCESSWIRE / June 16, 2020 / Wrap Technologies, Inc. (the "Company" or "Wrap") (NASDAQ:WRTC), an innovator of modern policing solutions, today reported the following statement about the Company's BolaWrap device, released by Arief Pujianto – Police Head of Division, Information & Logistics, Logistics Department of Indonesia National Police force:

"BolaWrap from Wrap Technologies (USA) is a very good restraining tool for Police Officer on the field to fight crimes in various kind of criminal actions such as robbery, assault and any other kind of criminal actions that could happen anytime within the civilians. Without inflicting any pain in the restraining attempt our frontlines officer would not be violating human rights.

This is important due to recently rising crime rates and current COVID-19 pandemics that cause fears and concerns to Indonesian citizens when going out of their home to do their daily activities.

BolaWrap has been tested by police officer and myself as responsible committee has proven its effectivity on restraining suspects. No need to use firearms and avoid any human rights violation accusation to police officers on the field."

Previously the Company reported an initial deposit placed by its distributor in Indonesia. Last week the Company fulfilled the balance of that order.

The Company's distributor secured a contract with the Indonesian National Police force following successful BolaWrap demonstrations across the country. The Company provided the Indonesian National Police force with custom BolaWrap devices with the police force's logo and matching uniform colors.

"Mr. Pujianto's statement reflects their understanding of the value of our BolaWrap remote restraint device as the only tool for law enforcement that is not designed to cause pain when used on noncompliant subjects," said Tom Smith, President of Wrap Technologies. "After visiting and demonstrating in Indonesia last year, it is great to see their initial order come to fruition as the interest from both the domestic and international communities continues to grow."

Highlights from the BolaWrap demonstrations in Indonesia can be found here.

About Wrap Technologies (NASDAQ:WRTC)

Wrap Technologies is an innovator of modern policing solutions. The Company's BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar® tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the Company's Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. For information on the Company please visit www.wraptechnologies.com. Examples of recent media coverage are available as links under the "Media" tab of the website.

Trademark Information: BolaWrap and Wrap are trademarks of Wrap Technologies, Inc. All other trade names used herein are either trademarks or registered trademarks of the respective holders.

Cautionary Note on Forward-Looking Statements – Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, total addressable market and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ability to successful implement training programs for the use of its products; the Company's ability to manufacture and produce product for its customers; the Company's ability to develop sales for its new product solution; the acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company's product solution; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the business impact of health crises or outbreaks of disease, such as epidemics or pandemics; the ability to obtain export licenses for counties outside of the US; the ability to obtain patents and defend IP against competitors; the impact of competitive products and solutions; and the Company's ability to maintain and enhance its brand, as well as other risk factors included in the Company's most recent annual report on Form 10-K, quarterly report on Form 10-Q and other SEC filings. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

WRAP TECHNOLOGIES CONTACT:
Paul M. Manley
VP – Investor Relations
612-834-1804
pmanley@wraptechnologies.com

SOURCE: Wrap Technologies, Inc.

ReleaseID: 594024

HOUSTON, TX / ACCESSWIRE / June 16, 2020 / Camber Energy, Inc. (NYSE American:CEI) ("Camber") and Viking Energy Group, Inc. (OTCQB:VKIN) ("Viking") are pleased to announce that on June 4, 2020, Camber filed with the Securities and Exchange Commission (SEC), a Registration Statement on Form S-4, including a preliminary joint proxy statement relating to the planned merger between Viking and Camber. The SEC has advised Camber that they are reviewing the Form S-4, and Camber anticipates comments thereon within the next few weeks in accordance with the customary SEC review process. The timing of the filing is consistent with the projected timetable set out in the joint press release issued by the companies on June 1, 2020 (https://finance.yahoo.com/news/camber-energy-inc-viking-energy-123000227.html) regarding previously planned next steps in the merger process. Separately, the parties entered into a second amendment to the merger agreement to extend the required closing date thereof from June 30, 2020 to September 30, 2020 (subject to further extensions through December 31, 2020, as per the original terms of the merger agreement), however the parties are hoping to close the merger before then if possible. An updated, estimated timeline of the closing of the merger is disclosed below:

Event

Projected Timeline*

Viking to file its Annual Report on Form 10-K for Viking's December 31, 2019 fiscal year-end

Completed

Viking to file Current Report on Form 8-K/A including financial statements related to its February 3, 2020 acquisition

Completed

Camber to file Registration Statement on Form S-4 with preliminary joint proxy statement with the Securities and Exchange Commission

Completed

Camber and Viking to receive Fairness Opinions regarding the planned Merger

Camber: Received in April 2020

Viking: Pending

Camber to file its Annual Report on Form 10-K for Camber's March 31, 2020 fiscal year end

June 2020

Camber and Viking to receive Shareholder Approval

Late Summer 2020

Camber to receive Stock Exchange Approval for the Merger

Late Summer 2020

Closing of the Merger

Late Summer 2020

*Estimate only. There is no guarantee items will be completed by such date, or at all. Such a timeline may also need to be extended in connection with delays caused by the Covid-19 pandemic and governmental responses to such pandemic, the SEC's review of the registration statement, or other matters outside of the control of the parties.

Details regarding the planned merger, along with copies of the definitive Agreement and Plan of Merger and First Amendment to the Agreement and Plan of Merger signed by the parties on February 3, 2020 and May 27, 2020, respectively, were included in Viking's and Camber's Current Reports on Form 8-K filed with the Securities and Exchange Commission on February 5, 2020 and June 1, 2020, respectively, and are available under "Investors" – "SEC filings" at www.vikingenergygroup.com and www.camber.energy.

As disclosed previously, the planned merger contemplates Camber issuing newly-issued shares of common stock to the equity holders of Viking in exchange for 100% of the outstanding equity securities of Viking by means of a reverse triangular merger in which a newly formed wholly-owned subsidiary of Camber will merge with and into Viking, with Viking continuing as the surviving corporation and as a wholly-owned subsidiary of Camber after the Merger. If the closing of the Merger occurs (the "Closing"), the Viking equity holders prior to the Merger will own approximately 80% of Camber's issued and outstanding common stock immediately after the Merger, and the Camber equity holders prior to the Merger shall own approximately 20% of Camber's issued and outstanding common stock immediately after the Merger, subject to adjustment mechanisms set out in the Merger Agreement, as amended, and in each case on a fully-diluted, as-converted basis as of immediately prior to the Closing (including options, warrants and other rights to acquire equity securities of Viking or Camber), but without taking into account any shares of common stock issuable to the holder of Camber's Series C Preferred Stock upon conversion of the Series C Preferred Stock. Completion of the Merger is subject to a number of closing conditions, as set out in the Merger Agreement.

James Doris, President & CEO of Viking, stated, "We remain committed to working diligently to complete steps necessary to close the merger, and firmly believe the combination of the two companies will be extremely beneficial to all stakeholders."

Louis G. Schott, Interim CEO of Camber, stated, "Camber is working with its auditors on finalizing the company's Annual Report for the fiscal year ended March 31, 2020, which we plan to file in the next week or so, prior to the SEC's required filing deadline, and we look forward to closing the merger by the end of the Summer after addressing SEC comments on the Form S-4, which are standard in transactions such as the merger."

About Viking:

Viking is an independent exploration and production company focused on the acquisition and development of oil and natural gas properties in the Gulf Coast and Mid-Continent region. The company owns oil and gas leases in Texas, Louisiana, Mississippi and Kansas. Viking targets undervalued assets with realistic appreciation potential.

About Camber:

Based in Houston, Texas, Camber Energy (NYSE American:CEI) is a growth-oriented, independent oil and gas company engaged in the development of crude oil, natural gas and natural gas liquids in Texas. For more information, please visit the company's website at www.camber.energy.

Forward-Looking Statements

Certain of the matters discussed in this communication which are not statements of historical fact constitute forward-looking statements that involve a number of risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "would," "will," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify forward-looking statements but are not the exclusive means of identifying these statements.

Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, the occurrence of any event, change or other circumstances that could give rise to the parties failing to complete the merger on the terms disclosed, if at all, the right of one or both of Viking or Camber to terminate the merger agreement and the result of such termination; the outcome of any legal proceedings that may be instituted against Viking, Camber or their respective directors; the ability to obtain regulatory approvals and other consents, and meet other closing conditions to the merger on a timely basis or at all, including the risk that regulatory approvals or other consents required for the merger are not obtained on a timely basis or at all, or which are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction; the ability to obtain approval by Viking stockholders and Camber stockholders on the expected schedule; required closing conditions which may not be able to be met and/or consents which may not be able to be obtained; difficulties and delays in integrating Viking's and Camber's businesses; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties, including, but not limited to, as a result of the recent volatility in oil and gas prices and the status of the economy (both US and global) due to the Covid-19 pandemic and actions taken to slow the spread of Covid-19; risks that the transaction disrupts Viking's or Camber's current plans and operations; failing to fully realize anticipated cost savings and other anticipated benefits of the merger when expected or at all; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the merger; the ability of Camber to obtain the approval of its Series C Preferred Stock holder to close the Merger; the ability of Viking or Camber to retain and hire key personnel; the diversion of management's attention from ongoing business operations; uncertainty as to the long-term value of the common stock of the combined company following the merger; the continued availability of capital and financing prior to, and following, the merger; the business, economic and political conditions in the markets in which Viking and Camber operate; and the fact that Viking's and Camber's reported earnings and financial position may be adversely affected by tax and other factors.

Other important factors that may cause actual results and outcomes to differ materially from those contained in the forward-looking statements included in this communication are described in the Form S-4, and Viking's and Camber's publicly filed reports, including Viking's Annual Report on Form 10-K for the year ended December 31, 2019, Camber's Annual Report on Form 10-K for the year ended March 31, 2019 and subsequently filed Quarterly Reports on Form 10-Q.

Viking and Camber caution that the foregoing list of important factors is not complete, and they do not undertake to update any forward-looking statements that either party may make except as required by applicable law. All subsequent written and oral forward-looking statements attributable to Viking, Camber or any person acting on behalf of either party are expressly qualified in their entirety by the cautionary statements referenced above.

Additional Information and Where to Find It

In connection with the proposed merger, on June 4, 2020 Camber filed with the SEC a registration statement on Form S‑4 to register the shares of Camber's common stock to be issued in connection with the merger. The registration statement includes a preliminary joint proxy statement/prospectus which, when finalized, will be sent to the respective stockholders of Viking and Camber seeking their approval of their respective transaction-related proposals. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE FINAL REGISTRATION STATEMENT ON FORM S-4 AND THE RELATED JOINT PROXY STATEMENT/PROSPECTUS INCLUDED WITHIN THE REGISTRATION STATEMENT ON FORM S‑4, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED MERGER, WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT VIKING, CAMBER AND THE PROPOSED MERGER.

Investors and security holders may obtain copies of these documents free of charge through the website maintained by the SEC at www.sec.gov or from Viking at its website, www.Viking.com, or from Camber at its website, www.Camber.energy. Documents filed with the SEC by Viking will be available free of charge by accessing Viking's website at www.vikingenergygroup.com under the heading "Investors" – "SEC Filings", or, alternatively, by directing a request by telephone or mail to Viking Energy Group, Inc. at 15915 Katy Freeway, Suite 450, Houston, Texas, 77094, (281) 404-4387, and documents filed with the SEC by Camber will be available free of charge by accessing Camber's website at www.camber.energy under the heading "Investors" – "SEC Filings", or, alternatively, by directing a request by telephone or mail to Camber Energy, Inc. at 1415 Louisiana, Suite 3500, Houston, Texas, 77002, (210) 998-4035.

Participants in the Solicitation

Viking, Camber and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the respective stockholders of Viking and Camber in respect of the proposed merger under the rules of the SEC. Information about Viking's directors and executive officers is available in Viking's Annual Report on Form 10-K for the year ended December 31, 2019. Information about Camber's directors and executive officers is available in Camber's Annual Report on Form 10-K for the year ended March 31, 2019 and its definitive proxy statement for its 2020 annual meeting of shareholders. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the final joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the merger when they become available. Investors should read the final joint proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from Viking or Camber using the sources indicated above.

No Offer or Solicitation

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

SOURCE: Camber Energy, Inc.

ReleaseID: 594011

ZHUHAI, CHINA / ACCESSWIRE / June 16, 2020 / Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) ("Powerbridge" or the "Company"), a global trade software applications and technology services provider, is pleased to announce the launch of Powerbridge Data Solutions, a general and intelligent self-help service platform of full stack. Powerbridge Data Solutions aims at the realization of "AI energizing Big Data" through platform-based functions, which enable users to have data exploration and enjoy the benefit from data.

Stewart Lor, President and Chief Financial Officer of Powerbridge Technologies, commented, "We are really excited about this launch of Powerbridge Data Solutions, as our team has been hard at work developing capabilities of artificial intelligence to empower big data. We believe we have a superior offering compared with other intelligent data platforms due to our greater emphasis on the integration of AI technologies and the users' experience. Our usage experience is centered upon deep integration of Big Data and AI, intelligent and self-help experience of application, framework of componentized platform service and effective support of data intelligent ecological construction. Our customers had been seeking such a solution and helped drive our creation of Powerbridge Data Solutions and we look forward to early adopters and users."

Key Features of Powerbrigde Data Solutions:

Multi-source data access – Powerbridge Data Solutions provides different data collection tools, which is able to access regular relational databases and unstructured data such as text, video and audio.

Improving the data value – Powerbridge Data Solutions provides data source management function and which is able to convert scattered and non-standardized data into standardized and business-meaning themed data. Meanwhile, it provides data sharing and value-added functions such as data mining, data mapping and data recommendation and governance.

Lowering AI application threshold – Componentized modeling, self-service model design and configurable machine learning help users in completing the data mining process quickly. The models are able to quickly convert data mining into scenario-based applications, which greatly lowers the threshold and simplified the use of Big Data and AI application.

Enriching the presentation of data – Powerbridge Data Solutions provides fast Data Visualization and AI analysis that helps to generate suggestion during the decision making process, which improves decision making accuracy and efficiency.

The integration of Big Data, AI, Cloud Computing, Internet and IoT is the trend of industrial and technologies development. Powerbridge Data Solutions is starting with "Big Data+AI", but will continuously integrates new technologies to innovate intelligent application for global trade industry. With the benefits of China's Belt and Road Strategy Powerbridge Data Solutions faces new opportunities in the international market and plays an important role in "Big Data + AI" application

About Powerbridge

Powerbridge Technologies Co., Ltd. (Nasdaq: PBTS) is a provider of software applications and technology solutions and services to corporate and government customers primarily located in China. Founded in 1997, Powerbridge pioneered global trade software applications with a vision to make global trade operations easier for customers. Since inception, Powerbridge has continued to innovate and deliver solutions and services to address the changing needs of thousands of customers. Powerbridge's mission is to make global trade easier by empowering all players in the ecosystem. For more information, visit www.powerbridge.com/en

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements; specifically, the Company's statements regarding listing on the NASDAQ Capital Market and the IPO are forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Corporate:
Powerbridge Technologies Co., Ltd.
Stewart Lor
President and Chief Financial Officer
Email: stewartlor@powerbridge.com

Investor Relations:
ClearThink
Phone: 917-658-7878
nyc@clearthink.capital
Email: IR@powerbridge.com

SOURCE: Powerbridge Technologies Co., Ltd.

ReleaseID: 593925

IRVINE, CA / ACCESSWIRE / June 16, 2020 / Terra Tech Corp. (OTCQX:TRTC) ("Terra Tech") or (the "Company") today announced that it will release its First Quarter 2020 results on Thursday, June 18, 2020 after U.S. markets close.

The company will also host a conference call on Thursday, June 18, 2020 at 4:30 PM Eastern Time.

Dial-In Number: 1-857-232-0157

Access Code: 422095

Matthew Morgan, CEO of Terra Tech Corp. will be answering shareholder questions at the end of the call. Should you have questions during or prior to the conference call please send an email to TRTC@kcsa.com with TRTC Question in the subject line. Mr. Morgan will answer as many questions as time will allow.

For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/trtc/. An archived version of the webcast will also be available on the investor relations section of the company's website.

To be added to the Terra Tech email distribution list, please email TRTC@kcsa.com with TRTC in the subject line.

About Terra Tech

Terra Tech, which recently merged with OneQor Pharmaceutical, is a holding company with a portfolio of investments focused on cannabis agricultural assets in the THC market and the research, development and commercialization of cannabinoid-based products. Backed by innovative science and best-in-class manufacturing, the company's mission is to deliver top-tier cannabis and cannabinoid-based products across the wide range of emerging consumer markets for plant-based health products, including CBD, pharmaceuticals and consumer brands.

Cautionary Language Concerning Forward-Looking Statements

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Terra Tech Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after such date.

Contact

Philip Carlson
KCSA Strategic Communications
TRTC@kcsa.com
212-896-1238

SOURCE: Terra Tech Corp.

ReleaseID: 593989

Product Offering Poised to Generate Significantly more Revenue in 3rd Quarter

BOCA RATON, FL / ACCESSWIRE / June 16, 2020 / StemSation International, Inc. (OTC PINK:STSN) – a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces its second product, a fast-acting and exclusive formula named ProStem PSP™ for joint and muscle health (https://www.stemsation.global/www/en/us/item/10016/ProStem-PSP-ProStem-PSP/) is now in U.S. distribution and available for sale through its network of Independent Wellness Advocates ("IWA's").

Distribution will ramp up this 3rd quarter to include Europe, increasing revenue as consumers continue to take more personal responsibility for their health and wellness during these unprecedented times. StemSation's flexible Direct Selling business model is also an excellent opportunity for individuals to earn money from home, more important today than ever before.

Developed by Dr. Mira Gadzala, a highly respected PhD and board-certified Alternative Medical Practitioner, this innovative product provides a novel combination of highly effective and clinically proven nutrients and delivery system that helps to form a strong and long-lasting foundation for joint and muscle health, natural nourishment and repair, collagen structure, and flexibility. The highly potent antioxidants and other natural compounds in ProStem PSP also support the cellular energy processes, and circulatory and immune system responses that are pivotal aspects in joint and muscle health and allows the body to function on more optimum and healthy level. https://www.youtube.com/watch?v=0JVqgbI1AoM

Ray C. Carter, Jr., CEO of StemSation stated "Our initial flagship product StemRCM, supporting immune system health, is being met with much enthusiasm by consumers and healthcare practitioners alike. Now with the addition of our second product, ProStem PSP, we enter the very large and fast-growing area of joint and muscle health. It's topical companion product, StemFlexTM, will also be available soon, further making our products unmatched in efficacy and innovation."

StemSation is a company with a long-term ‘health mission', ambitious research goals, and innovative, holistic approaches to health & wellness, and healthy longevity. Its product line shows a new pathway to wellness.

ABOUT STEMSATION INTERNATIONAL, INC.

StemSation International, Inc. (OTC "STSN") develops, manufactures and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body by using a direct selling model in which Independent Wellness Advocates ("IWAs") advertise and sell its products directly to consumers. StemSation is headquartered in Boca Raton, Florida, website can be found at www.stemsation.global and social media can be found at https://www.facebook.com/StemsationGlobal/, https://twitter.com/StemsationI , https://www.instagram.com/stemsationglobal/ and https://www.linkedin.com/company/stemsation-international-inc/.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

FOR INFORMATION, PLEASE CONTACT:

Nicholas B. Panza, Vice-President
StemSation International, Inc.
7777 Glades Road
Suite 203
Boca Raton, FL 33434
npanza@stemsationusa.com
(561) 245-7454

SOURCE: StemSation International, Inc.

ReleaseID: 593986

Goal of XCART collaboration to optimize XCART process, develop manufacturing processes and to ultimately dose non-Hodgkin lymphoma (NHL) patients
Pharmsynthez to act as primary contract research organization coordinating activities throughout collaboration
Academic Institutions include:

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IBCh RAS)
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology
Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus
Vitebsk Regional Clinical Oncological Center

FRAMINGHAM, MA / ACCESSWIRE / June 16, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today it has entered into a master services agreement ("MSA") with PJSC Pharmsynthez to advance the development of the XCART technology for B-cell malignancies. Under the terms of the MSA, Pharmsynthez will act as the primary contract research organization ("CRO") to assist in managing the collaboration with multiple academic institutions in Russia and Belarus.

The initial stage of the collaboration will include an exploratory trial to evaluate and refine the XCART front-end process of target identification, screening and lead characterization, in a real-world clinical setting. This exploratory stage entails enrollment of NHL patients, obtaining tumor biopsies and then refining the XCART front-end methods. Subsequently the collaboration may be expanded to include development and qualification of manufacturing processes for producing autologous XCART T-cells. If successful, the Company has the potential to expand the clinical study component to dose a number of NHL patients in a Phase 1 dosing study.

"This agreement represents another significant milestone for the Company and provides access to a number of world-renowned academic institutions, researchers and clinical investigators in the area of oncology and hematology. Additionally, we are excited to again be working with the Shemyakin and Ovchinnikov Institute as they are intimately familiar with the XCART platform having been one of the primary inventors," commented Jeffrey Eisenberg, Chief Executive Officer of Xenetic. "Coupled with our recently announced collaboration with Scripps Research, we believe we are well-positioned to execute on our strategic development plan as we work to advance this innovative technology, which we believe has the potential to address a significant unmet need in NHL."

Alexander Gabibov, academic, Head of the Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry RAS, commented, "The XCART platform was thoughtfully designed to target personalized, patient-specific tumor neoantigens and has demonstrated encouraging potential. Our team is uniquely positioned to carry out this important foundational work and, through this collaboration is able to leverage the additional expertise from the Belarus academic institutions. We are pleased to continue our collaboration with Xenetic through this agreement and look forward to helping to advance the XCART platform towards first-in-human dosing."

The XCART technology platform was designed to utilize an established screening technique to identify polypeptide domains that selectively bind to the unique B-cell receptor ("BCR") on the surface of an individual lymphoma patient's malignant B-cell clones. This BCR-selective targeting domain is engineered into the antigen-binding domain of a chimeric antigen receptor ("CAR"), creating the possibility of a CAR T treatment that should only recognize a given patient's malignant B-cell clones. An expected result for XCART is limited off-tumor toxicities, such as B-cell aplasia. Xenetic's clinical development program will seek to confirm the early preclinical results, and to demonstrate a more attractive safety profile than existing therapies.

About Pharmsynthez

Pharmsynthez PJSC (MOEX: LIFE) is a Russian pharmaceutical company that develops new medicines, drug technologies for organ-specific delivery, and innovative methods of manufacturing pharmaceutical ingredients. The company is engaged in production and sale of both medicines for the treatment of respiratory diseases (original OM) and active pharmaceutical ingredients (API). The company has a research and production complex in Kapitolovo, commissioned in 2001. Pharmsynthez actively cooperates with North American, Canadian and European companies in the field of chemical compounds and API production.

About Shemyakin

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry RAS – the largest center of physical and chemical biology and biotechnology in Russia, employs more than 1000 employees in more than 40 laboratories. The Institute is part of the Department of Biological Sciences of the Russian Academy of Sciences and leads the work related to the chemical study of living matter. The Institute conducts research on the molecular mechanisms of various life processes, their practical use in the interests of medicine and agriculture, and also develops fundamental and applied aspects of biotechnology. The international advisory board of the IBCh RAS includes Nobel laureates Robert Huber, Aaron Chehanover, Kurt Wutrich, Sydney Altman, Richard Roberts, Roger Kornberg, as well as Professor of Scripps Institute Richard Lerner and head of the Department of Pharmacology at Yale University School of Medicine Joseph Schlessinger.

About Xenetic Biosciences

Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART™ has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.

Additionally, Xenetic is leveraging PolyXen®, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen® has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and receives royalty payments under this agreement.

For more information, please visit the Company's website at www.xeneticbio.com and connect on Twitter, LinkedIn, and Facebook.

Forward-Looking Statements

This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical facts may constitute forward-looking statements within the meaning of the federal securities laws. These statements can be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning, including, but not limited to, statements regarding the Company's collaboration with Pharmsynthez, including, if successful, the potential to expand the collaboration to include development and qualification of manufacturing processes for producing autologous XCART CAR T cells, the Company's belief that we are well-positioned to execute on our strategic development plan as we work to advance our innovative technology, the Company's belief that XCART has the potential to address a significant unmet need in NHL, anticipations regarding advancing the XCART platform towards first-in-human dosing, expected results for XCART including limited off-tumor toxicities, such as B-cell aplasia, expectations that the Company's clinical development program will confirm the early preclinical results and demonstrate a more attractive safety profile than existing therapies, the Company's plans to initially apply the XCART technology to advance cell-based therapeutics by targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas, the Company's expectations that XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications, the Company's plans to leverage PolyXen® by partnering with biotechnology and pharmaceutical companies, and the Company's expectation regarding receipt of royalty payments under the exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. Any forward-looking statements contained herein are based on current expectations, and are subject to a number of risks and uncertainties. Many factors could cause our actual activities, performance, achievements, or results to differ materially from the activities and results anticipated in forward-looking statements. Important factors that could cause actual activities, performance, achievements, or results to differ materially from such plans, estimates or expectations include, among others, (1) unexpected costs, charges or expenses resulting from the acquisition of XCART; (2) uncertainty of the expected financial performance of the Company following completion of the acquisition of XCART; (3) failure to realize the anticipated potential of the XCART technology; (4) the ability of the Company to implement its business strategy; (5) failure of Pharmsynthez to perform its obligations under the MSA; (6) failure of the Company and Pharmsynthez to reach agreements with the contract sites on terms favorable to the Company, or at all, and (7) other risk factors as detailed from time to time in the Company's reports filed with the SEC, including its annual report on Form 10-K, periodic quarterly reports on Form 10-Q, periodic current reports on Form 8-K and other documents filed with the SEC. The foregoing list of important factors is not exclusive. In addition, forward-looking statements may also be adversely affected by general market factors, general economic and business conditions, including potential adverse effects of public health issues, such as the COVID-19 outbreak on economic activity, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new product candidates and indications, manufacturing issues that may arise, patent positions and litigation, among other factors. The forward-looking statements contained in this press release speak only as of the date the statements were made, and the Company does not undertake any obligation to update forward-looking statements, except as required by law.

Contact:

JTC Team, LLC
Jenene Thomas
(833) 475-8247
xbio@jtcir.com

SOURCE: Xenetic Biosciences, Inc.

ReleaseID: 593969